Near Infrared Spectroscopy for Single Ventricle Heart
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores how near infrared spectroscopy (NIRS) can help monitor infants with single ventricle heart disease. Researchers aim to predict when an infant might need to return to the hospital or undergo an intervention by examining how their body uses oxygen. The study also investigates any link between oxygen use and factors like weight gain and brain development. Infants who may qualify for this trial are those under 6 months old with specific heart conditions, not currently hospitalized, and awaiting the Glenn operation. As an unphased trial, this study provides a unique opportunity to contribute to groundbreaking research that could enhance monitoring and outcomes for infants with heart conditions.
Will I have to stop taking my current medications?
The trial information does not specify whether participants must stop taking their current medications.
What prior data suggests that this technique is safe for use in single ventricle heart patients?
Research has shown that near-infrared spectroscopy (NIRS) is generally safe for people. Studies have found that it effectively checks oxygen levels in the body without causing harm. NIRS can detect early signs of issues like low oxygen (desaturation) and irregular heartbeats (arrhythmia) about 10-15 seconds before symptoms appear, allowing doctors to act quickly.
No reports of serious side effects have emerged from using NIRS. This non-invasive tool sits on the skin and uses light to measure blood oxygen levels. It is considered safe because it doesn't involve needles or cuts. Overall, NIRS offers a promising way to monitor health conditions without adding risk.12345Why are researchers excited about this trial?
Researchers are excited about using Near Infrared Spectroscopy (NIRS) for single ventricle heart conditions because it offers a non-invasive way to monitor patients' renal health in real time. Unlike traditional methods that might rely on blood tests or imaging to assess kidney function, NIRS uses light to measure tissue oxygenation directly, providing immediate feedback without discomfort. This innovative approach could lead to more responsive and personalized care, potentially improving outcomes for patients with complex heart conditions.
What evidence suggests that near infrared spectroscopy is effective for single ventricle heart?
Research has shown that near-infrared spectroscopy (NIRS), which participants in this trial will use, can help monitor oxygen levels in the body. This is crucial for patients with single ventricle heart conditions. One study found that NIRS could identify low cardiac output, when the heart isn't pumping enough blood, in these patients. This is important because knowing these oxygen levels can help doctors make better treatment decisions. Another study found that NIRS readings were connected to heart function after surgery. These findings suggest that NIRS may be a useful tool for checking heart health in patients with single ventricle conditions.46789
Who Is on the Research Team?
Joshua Wong, MD
Principal Investigator
Advocate Children's Hospital
Are You a Good Fit for This Trial?
This trial is for individuals with a heart condition known as Single Ventricle Heart. It's specifically looking at patients in the interstage period, which is the time between their first and second heart surgeries.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Interstage Monitoring
Participants have renal near infrared spectroscopy recorded in clinic to assess oxygen extraction ratio and its correlation with clinical outcomes
Follow-up
Participants are monitored for safety and effectiveness after the interstage monitoring period
What Are the Treatments Tested in This Trial?
Interventions
- Near Infrared Spectroscopy
Find a Clinic Near You
Who Is Running the Clinical Trial?
Advocate Hospital System
Lead Sponsor